InterCure Ltd

Contributing Author

Recent Articles by InterCure Ltd

5 hours	InterCure Secures NIS 22 Million in Private Placement Financing Led by Leading Pharma-Focused Hedge Funds INCR +18.45% GlobeNewswire
Jun-15	InterCure Initiates Strategic Review of U.S. Medical Cannabis Opportunities Following Historic Federal Rescheduling and Completes the Initial closing of Botanico Acquisition INCR +9.27% GlobeNewswire
Apr-30	InterCure Announces 2025 Results with NIS 270 Million in Revenue and Positive Operating Cash Flow INCR +5.45% INCR GlobeNewswire
Mar-03	InterCure Receives Nasdaq Notification Regarding Minimum Bid Requirement INCR GlobeNewswire
Feb-19	InterCure Announces Preliminary Estimated 2025 Revenue of NIS 265 Million, Positive Adjusted EBITDA and Cash of NIS 43 Million INCR -5.78% GlobeNewswire
Feb-19	InterCure Announces Preliminary Estimated 2025 Revenue of NIS 265 Million, Positive Adjusted EBITDA and Cash¹ of NIS 43 Million INCR -5.78% GlobeNewswire
Nov-03	InterCure and Cannasoul Sign Strategic Investment and Collaboration Agreements to Advance Cannabis Science and Pharmaceutical Innovation INCR GlobeNewswire
Oct-08	InterCure Reports First Half 2025 Results with NIS 130 Million in Revenue and Positive Operating Cash Flow INCR GlobeNewswire
Oct-08	InterCure Reports First Half 2025 Results with NIS 130 Million in Revenue and Positive Operating Cash Flow INCR GlobeNewswire
Sep-19	InterCure Announces Strategic Acquisition of ISHI, Unlocking Access to Premium U.S. Cannabis Technology and Brands INCR GlobeNewswire